Takeuchi T - Search Results

1

Pathogenic and protective roles of extracellular vesicles in neurodegenerative diseases.

Takeuchi T. Takeuchi T. J Biochem. 2021 Mar 5;169(2):181-186. doi: 10.1093/jb/mvaa131. J Biochem. 2021. PMID: 33196835 Review.

2

Emerging roles of extracellular vesicles in polyglutamine diseases: Mutant protein transmission, therapeutic potential, and diagnostics.

Takeuchi T, Nagai Y. Takeuchi T, et al. Neurochem Int. 2022 Jul;157:105357. doi: 10.1016/j.neuint.2022.105357. Epub 2022 May 4. Neurochem Int. 2022. PMID: 35525394 Review.

3

Comparison of serum and plasma as a source of blood extracellular vesicles: Increased levels of platelet-derived particles in serum extracellular vesicle fractions alter content profiles from plasma extracellular vesicle fractions.

Zhang X, Takeuchi T, Takeda A, Mochizuki H, Nagai Y. Zhang X, et al. Among authors: takeuchi t. PLoS One. 2022 Jun 24;17(6):e0270634. doi: 10.1371/journal.pone.0270634. eCollection 2022. PLoS One. 2022. PMID: 35749554 Free PMC article. Review.

4

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases.

Takeuchi T, Nagai Y. Takeuchi T, et al. Brain Sci. 2017 Oct 11;7(10):128. doi: 10.3390/brainsci7100128. Brain Sci. 2017. PMID: 29019918 Free PMC article. Review.

5

Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis.

Nakase I, Tadokoro A, Kawabata N, Takeuchi T, Katoh H, Hiramoto K, Negishi M, Nomizu M, Sugiura Y, Futaki S. Nakase I, et al. Among authors: takeuchi t. Biochemistry. 2007 Jan 16;46(2):492-501. doi: 10.1021/bi0612824. Biochemistry. 2007. PMID: 17209559

6

Peptide-based therapeutic approaches for treatment of the polyglutamine diseases.

Takeuchi T, Popiel HA, Futaki S, Wada K, Nagai Y. Takeuchi T, et al. Curr Med Chem. 2014;21(23):2575-82. doi: 10.2174/0929867321666140217124038. Curr Med Chem. 2014. PMID: 24533807 Review.

7

Intercellular chaperone transmission via exosomes contributes to maintenance of protein homeostasis at the organismal level.

Takeuchi T, Suzuki M, Fujikake N, Popiel HA, Kikuchi H, Futaki S, Wada K, Nagai Y. Takeuchi T, et al. Proc Natl Acad Sci U S A. 2015 May 12;112(19):E2497-506. doi: 10.1073/pnas.1412651112. Epub 2015 Apr 27. Proc Natl Acad Sci U S A. 2015. PMID: 25918398 Free PMC article.

8

E46K mutant α-synuclein is more degradation resistant and exhibits greater toxic effects than wild-type α-synuclein in Drosophila models of Parkinson's disease.

Sakai R, Suzuki M, Ueyama M, Takeuchi T, Minakawa EN, Hayakawa H, Baba K, Mochizuki H, Nagai Y. Sakai R, et al. Among authors: takeuchi t. PLoS One. 2019 Jun 26;14(6):e0218261. doi: 10.1371/journal.pone.0218261. eCollection 2019. PLoS One. 2019. PMID: 31242217 Free PMC article.

9

Alternative mitochondrial quality control mediated by extracellular release.

Choong CJ, Okuno T, Ikenaka K, Baba K, Hayakawa H, Koike M, Yokota M, Doi J, Kakuda K, Takeuchi T, Kuma A, Nakamura S, Nagai Y, Nagano S, Yoshimori T, Mochizuki H. Choong CJ, et al. Among authors: takeuchi t. Autophagy. 2021 Oct;17(10):2962-2974. doi: 10.1080/15548627.2020.1848130. Epub 2020 Dec 10. Autophagy. 2021. PMID: 33218272 Free PMC article.

10

Two-step screening method to identify α-synuclein aggregation inhibitors for Parkinson's disease.

Hideshima M, Kimura Y, Aguirre C, Kakuda K, Takeuchi T, Choong CJ, Doi J, Nabekura K, Yamaguchi K, Nakajima K, Baba K, Nagano S, Goto Y, Nagai Y, Mochizuki H, Ikenaka K. Hideshima M, et al. Among authors: takeuchi t. Sci Rep. 2022 Jan 10;12(1):351. doi: 10.1038/s41598-021-04131-9. Sci Rep. 2022. PMID: 35013421 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

5,611 results

Search Page